
ANGPTL4 & Adipose RNA Update
ANGPTL4 & Adipose RNA Update β Monday August 17, 2026
The week's strongest signal is a Molecular Therapy paper using antibody-targeted lipid-coated nanoparticles to deliver siRNA into a specific pathogenic adipose stromal cell population β a concrete adipose-RNA-delivery advance β alongside a cluster of new mechanistic data tying ANGPTL4 to cancer metastasis, immune evasion, and renal fibrosis, plus a registered systematic-review protocol on ANGPTL3/ANGPTL4/APOC3 inhibitors for hypertriglyceridemia-driven pancreatitis.

